Thermo Fisher Q2 Earnings: Marginal Revenue Dip, Completes Olink Acquisition, Lifts Annual Profit Outlook
Portfolio Pulse from Vandana Singh
Thermo Fisher Scientific Inc. (NYSE: TMO) reported a slight dip in Q2 revenue but beat earnings expectations. The company completed the acquisition of Olink and raised its annual profit outlook. Despite a premarket stock dip, the outlook remains positive.
July 24, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Thermo Fisher Scientific reported Q2 revenue of $10.54 billion, a 1% YoY decline, but beat earnings expectations with an adjusted EPS of $5.37. The company completed the acquisition of Olink and raised its annual profit outlook. Despite a premarket stock dip, the outlook remains positive.
Thermo Fisher's Q2 earnings beat expectations, and the completion of the Olink acquisition is a strategic move that could enhance future growth. The raised annual profit outlook is a positive indicator. Despite a premarket stock dip, the overall outlook remains positive.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100